Avalo Therapeutics (AVTX) Return on Invested Capital [ROIC] (2017 - 2023)
Avalo Therapeutics (AVTX) posted Return on Invested Capital [ROIC] of -248.65% for Q4 2023, up 44.56 percentage points from -293.21% a year earlier and up 12.76 percentage points from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Return on Invested Capital [ROIC] (2017 - 2023) Analysis & Trends
For FY2023, Avalo Therapeutics' Return on Invested Capital [ROIC] came in at -346.11%, down 229.86 percentage points from FY2022.
- Annual Return on Invested Capital [ROIC] shows a five-year change of -235.95 percentage points (FY2018 to FY2023).
- In prior years, Avalo Therapeutics' Return on Invested Capital [ROIC] was -116.24% in FY2022 (+87.40 pp) and -203.64% in FY2021.
- Quarterly Return on Invested Capital [ROIC] has run from a low of -312.41% in Q3 2022 to a high of -35.98% in Q3 2019 over five years.
- According to Business Quant data, Return on Invested Capital [ROIC] for the three prior quarters was -261.41% (Q3 2023), -200.55% (Q2 2023) and -230.73% (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 16.10% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 21.95% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 28.83% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 13.44% |
| 10 | Avalo Therapeutics | 653.59 Mn | 653.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -248.65% |
| Sep 30, 2023 | -261.41% |
| Jun 30, 2023 | -200.55% |
| Mar 31, 2023 | -230.73% |
| Dec 31, 2022 | -293.21% |
| Sep 30, 2022 | -312.41% |
| Sep 30, 2019 | -35.98% |
| Jun 30, 2019 | -93.50% |
| Mar 31, 2019 | -97.99% |
| Dec 31, 2018 | -99.24% |
| Sep 30, 2018 | -106.46% |
| Jun 30, 2018 | 16.00% |
| Mar 31, 2018 | 29.57% |
| Dec 31, 2017 | 47.68% |
| Sep 30, 2017 | 103.07% |
API Access
Avalo Therapeutics Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();